Systems and Methds for Use by an Implantable Medical Device for Controlling Vagus Nerve Stimulation Based on Heart Rate Reduction Curves and Thresholds to Mitigate Heart Failure

• US 20100114227A1
• Filed: 10/30/2008
• Published: 05/06/2010
• Est. Priority Date: 10/30/2008
• Status: Abandoned Application

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Cholette, Martin
• Application Number:
  US12/261,924
• Publication Number:
  US 20100114227A1
• Time in Patent Office: Days
• US Class Current: 607/17
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

Systems and techniques are provided for controlling vagus nerve stimulation (VNS) delivered by an implantable medical device for mitigating heart failure in a patient. In one mode, VNS therapy is set to levels just below a heart rate reduction threshold so as to deliver VNS near the highest stimulation levels that can be achieved without reducing patient heart rate. In this manner, a maximum level of heart failure mitigation can be achieved via VNS therapy without incurring the potentially adverse consequences of inducing bradycardia within the patient. In another mode, VNS therapy is instead controlled to deliver VNS above the threshold so as to mitigate heart failure while also selectively reducing heart rate, as may be appropriate in patients susceptible to cardiac ischemia. A controlled heart rate reduction curve may additionally or alternatively be determined for use in achieving target amounts of heart rate reduction.

Claims

1. A method for use with an implantable medical device for implant within a patient, the method comprising:

stimulating the vagus nerve of the patient in accordance with at least one adjustable vagus nerve stimulation (VNS) parameter while monitoring patient heart rate;

determining a heart rate reduction threshold level for the VNS parameter at which the stimulation begins to reduce heart rate; and

controlling further VNS based on the detected heart rate reduction threshold level.

2. The method of claim 1 wherein the VNS parameter includes one or more of stimulation pulse amplitude, width, frequency and shape.

3. The method of claim 1 wherein determining the heart rate reduction threshold level for the VNS parameter includes incrementally adjusting the VNS parameter until, at least, a predetermined minimum heart rate reduction level is detected.

4. The method of claim 3 wherein the predetermined minimum heart rate reduction level is in the range of two to three beats per minute (bpm).

5. The method of claim 3 wherein incrementally adjusting the VNS parameter is terminated if the patient'"'"'s heart rate falls below a predetermined minimum acceptable heart rate threshold.

6. The method of claim 1 wherein controlling further VNS is performed to deliver VNS without incurring any significant reduction in patient heart rate.

7. The method of claim 6 wherein controlling further VNS to deliver VNS without incurring any significant reduction in heart rate is performed to trigger only Type A and Type B vagus nerve fibers.

8. The method of claim 6 wherein controlling further VNS is performed by delivering VNS pulses at a predetermined percentage of the heart rate reduction threshold level.

9. The method of claim 8 wherein the predetermined percentage is in the range of 25-95%.

10. The method of claim 1 wherein controlling further VNS is performed to achieve a reduction in patient heart rate.

11. The method of claim 10 wherein controlling further VNS to achieve a reduction in heart rate reduction is performed to trigger Type C vagus nerve fibers along with Type A and Type B vagus nerve fibers.

12. The method of claim 10 wherein controlling further VNS is performed by delivering VNS pulses at a predetermined level above the heart rate reduction threshold level.

13. The method of claim 12 wherein controlling further VNS to achieve a reduction in heart rate includes:

determining a controlled heart rate curve for the patient representative of heart rate decrease as a function of increasing values of the VNS parameter;

determining a preferred amount of heart rate reduction for the patient;

determining a particular value for the VNS parameter sufficient to achieve the preferred amount of heart rate reduction based on the controlled heart rate curve; and

delivering further VNS using the particular value for the VNS parameter.

14. The method of claim 13 wherein controlling further VNS to achieve a reduction in heart rate is performed in response to the patient'"'"'s heart rate exceeding a predetermined tolerance threshold.

15. A system for use with an implantable medical device for implant within a patient, the system comprising:

a vagus nerve stimulation (VNS) device operative to deliver VNS to the heart of the patient in accordance with at least one adjustable VNS parameter;

a heart rate monitor;

a heart rate reduction threshold determination system operative to determine a threshold level for a selected VNS parameter at which VNS begins to reduce heart rate as measured by the heart rate monitor; and

a VNS controller operative to control further VNS based on the heart rate reduction threshold.

16. The system of claim 15 further including a controlled heart rate curve determination unit operative to determine a controlled heart rate curve for the patient representative of heart rate decrease within the patient as a function of increasing values of the VNS parameter.

17. The system of claim 15 wherein the VNS controller is further operative to control VNS based on the controlled heart rate curve.

18. A system for use with an implantable medical device for implant within a patient, the method comprising:

means for stimulating the vagus nerve in accordance with at least one vagus nerve stimulation (VNS) parameter while monitoring heart rate;

means for determining a threshold level for the VNS parameter at which the stimulation begins to reduce heart rate; and

means for controlling further VNS based on the detected threshold level.

19. A method for use with an implantable medical device for implant within a patient wherein the device is equipped to stimulate the vagus nerve of the patient in accordance with at least one adjustable vagus nerve stimulation (VNS) parameter, the method comprising:

determining a controlled heart rate curve for the patient representative of heart rate decrease within the patient as a function of increasing values of the VNS parameter;

determining a preferred amount of heart rate reduction for the patient;

determining a particular value for the VNS parameter sufficient to achieve the preferred amount of heart rate reduction based on the controlled heart rate curve; and

delivering VNS to the patient using the particular value for the VNS parameter.

20. A system for use with an implantable medical device for implant within a patient, the system comprising:

a vagus nerve stimulation (VNS) device operative to deliver VNS to the heart of the patient in accordance with at least one adjustable VNS parameter;

a heart rate monitor; and

a controlled heart rate curve determination system operative to determine a controlled heart rate curve for the patient representative of heart rate decrease within the patient as a function of increasing values of the adjustable VNS parameter; and

a VNS controller operative to control deliver of VNS to the patient based on the controlled heart rate curve.